Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.5 (
cathepsin D
)
4,130
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Progestins increase the activity and rate of synthesis of
cathepsin D
, a lysosomal aspartyl protease, in the uterine luminal epithelium in ovariectomized rats. Western blot analysis of luminal epithelial proteins determined that the progestin, medroxyprogesterone acetate (MPA) increased the 43-kDa form of
cathepsin D
by 7-fold in 24 hr, whereas estradiol increased the amount of the same form by only 2-fold. To examine the precursor-product relationship between
cathepsin D
proteins in the luminal epithelium and stroma-myometrium after progestin or estradiol treatment, uterine proteins were prelabeled by incubation with [35S]methionine in vitro,
cathepsin D
was isolated by immunoprecipitation, and equal amounts of labeled
cathepsin D
were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After each hormonal treatment in each uterine tissue, a 48-kDa precursor was processed into a 44-kDa
cathepsin D
product. Endoglycosidase H digestion of [35S]methionine-labeled
cathepsin D
from the luminal epithelium and stroma-myometrium of medroxyprogesterone-treated rats shifted the molecular masses of the
cathepsin D
proteins by approximately 5.7 kDa. To examine the contribution of increased mRNA to increased rates of
cathepsin D
synthesis, we measured levels of
cathepsin D
mRNA in uterine tissues after progestin and estrogen treatment. Total RNA was isolated from the uterine luminal epithelium and from the stroma-myometrium. Northern blot analysis identified a single 2.2-kb RNA band corresponding to the size expected for
cathepsin D
mRNA.
Medroxyprogesterone
increased levels of
cathepsin D
mRNA in the luminal epithelium (greater than 17-fold) and in the stroma myometrium (3-fold), with maximum increases at 9 hr after treatment. Estradiol also increased
cathepsin D
mRNA levels in both uterine tissues, but by only 2-fold. No hormonal effects on liver
cathepsin D
mRNA were observed. Increases in
cathepsin D
synthesis and activity in uterine tissues in response to progestin and estrogen appear to depend in part upon increased levels of mRNA.
...
PMID:Progestin and estrogen control of cathepsin D expression and processing in rat uterine luminal epithelium and stroma-myometrium. 138 74